Introduction
============

Recent technical advances in next generation sequencing have greatly accelerated discoveries in the field of molecular genetics, among which the importance of non-protein coding transcripts have been increasingly highlighted ([@B84]). In contrast to messenger RNAs (mRNAs), the term non-coding RNAs (ncRNAs) refers to a class of RNA transcripts that do not encode protein ([@B39]). It was estimated that only 1--2% RNA in human genome could code for proteins and ncRNAs constitute a vast majority of the human transcriptome ([@B21]). In addition to microRNAs (miRNAs), small interfering RNAs (siRNAs), long non-coding RNAs (lncRNAs) and small nuclear RNAs (snoRNAs), the recently recognized circular RNAs (circRNAs) represents a special type of ncRNAs that plays a central regulatory role in RNA metabolism ([@B35]).

As early as in the 1970s, several circRNAs were found in RNA viruses ([@B81]; [@B41]). However, they have long thought to be byproducts of mRNA splicing until recent technical advances of deep-sequencing revealed the existence of thousands of circRNAs in difference species ([@B56]; [@B76]; [@B107]). CircRNAs represent a novel class of widespread and diverse endogenous RNAs that, unlike linear RNAs, are characterized by a covalent bond linking the 5′ and 3′ ends ([@B30]). CircRNAs are generated from spliceosome-mediated precursor mRNA (pre-mRNA) splicing through a non-canonical splicing process in eukaryotes ([@B3]; [@B9]). Many circRNAs originate from protein coding genes and contain exonic sequences; however, they have long been considered as RNAs that do not encode any proteins ([@B30]; [@B102]). Nevertheless, recent studies have shown that a subset of circRNAs can be translated endogenously ([@B70]; [@B100]). Due to the absence of 3′ termini, circRNAs are resistant to degradation by exonuclease RNase R and thus being more stable than linear mRNAs ([@B9]). CircRNAs are evolutionarily conserved across multiple species ([@B44]; [@B79]) indicating their functional importance. Given their abundance, long half-life and species conservation, circRNAs may effectively regulate a wide range of physiological activities and pathological changes ([@B103]; [@B110]). Although the function of circRNAs remains largely uncharacterized, recent studies have shown that some circRNAs can bind other ncRNAs or proteins and thus regulating the expression of other or even their parental genes ([@B1]; [@B32]). Moreover, recent discoveries of translated products from certain circRNA also suggest that they may have specific biological functions ([@B70]; [@B100]).

Multiple recent studies have shown that circRNAs may play crucial roles in brain development and diseases. In a study testing the abundance of circRNAs in different organs, mammalian brain was found to have the highest amount of circRNAs among all tissues tested, including liver, lung, heart, and testis ([@B102]). In addition, circRNAs are especially highly enriched in synapses, and genes related to synapses can give rise to significantly abundant circRNAs ([@B22]; [@B79]; [@B87]). Interestingly, the expression levels of certain circRNAs can be much higher than the canonical linear transcripts of their parent genes during the central nervous system (CNS) development ([@B79]), indicating that circRNAs may have different functions than their linear counterparts. It is known that other kinds of ncRNAs, such as miRNAs play an essential role in the process of CNS development and diseases ([@B38]; [@B71]; [@B101]). CircRNAs can serve as competing endogenous sponges to miRNAs and therefore by regulating their activities, circRNAs can have notable influence upon the development and diseases of the CNS ([@B88]; [@B58]; [@B52]).

In this review, we describe the biogenesis and characteristics of circRNAs. Their potential functions and possible roles in CNS development and diseases are also discussed.

Biogenesis of circRNAs
======================

CircRNAs are derived from non-canonical splicing of precursor mRNAs (pre-mRNAs), which are regulated by the spliceosome and modulated by *cis*-regulatory elements and *trans*-acting factors ([@B106]; [@B30]; [@B5]). Through RNA sequencing of non-polyadenylated transcriptomes, thousands of circRNAs were detected in different types of cells and tissues, and overall, they comprise over 10% of the transcripts encoded by their parent genes. Although the same gene contains sequences of both circRNAs and linear protein-coding mRNAs, the expression levels of circRNAs and their linear counterparts do not always correlate, indicating the presence of a distinct regulation mechanism of biosynthesis between the circRNA and linear mRNA ([@B43]; [@B48]; [@B90]).

Canonical Spliceosomes Mediate Non-canonical circRNA Biogenesis
---------------------------------------------------------------

CircRNAs can arise from different regions of gene loci in eukaryotes, such as from exons (called exonic circRNA, or ecircRNA), from introns (called intronic circRNA, or ciRNA) or from both exons and introns (called exon--intron circRNA, or ElciRNA) ([@B54]; [@B105]) (**Figure [1A](#F1){ref-type="fig"}**). Nevertheless, most circRNAs are derived from exons of protein-coding genes through a non-canonical splicing process called 'back-splicing,' in which a downstream splice donor joins an upstream splice acceptor leading to exon circularization ([@B44]; [@B80]). The canonical splice machinery, however, is required for exon circularization as was shown by mutagenesis experiments ([@B10]; [@B86]). Since mRNAs that are generated from linear splicing is also mediated by the canonical splicesome, how circRNAs and mRNAs can both be generated from the same pre-mRNA remains to be an important question ([@B31]). Similar to mRNA splicing, the presence of canonical splice sites of bracketing exons can determine, to a large degree, the circularization rates ([@B6]; [@B96]; [@B105]). On the other hand, functional studies have elucidated that, during circular vs. linear splicing, different splice sites can be activated and the biogenesis of circRNAs and mRNAs may compete with each other ([@B89]; [@B5]). Moreover, there are other differences between canonical spliceosome mediated circRNA and mRNA biogenesis, which might largely determine which molecule will be predominantly generated from the pre-mRNA, leading to distinct expression patterns of circRNA and mRNA ([@B3]; [@B86]). For example, the efficiency of back-splicing is lower than those of the corresponding linear counterparts, perhaps because spliceosomes are inefficiently aggregated at back-splicing sites at the steady-state of circRNA production ([@B3]; [@B30]). Although the exact details on how the splicesome carry out exon circularization is not known, the canonical splice signals and canonical spliceosomal machinery are important in the processing of circRNAs biogenesis ([@B10]; [@B72]).

![Regulation of circRNA biogenesis. **(A)** mRNAs are generated from spliceosome-mediated canonical splicing, but circRNAs are generated from pre-mRNA splicing through a non-canonical splicing process. CircRNAs can arise from exons (called ecircRNA), from introns (called ciRNA) or from both exons and introns (called ElciRNA). **(B)** The flanking introns of circMbl have abundant MBL binding sites that are required for circMbl biogenesis. Therefore, MBL protein can control the production of the circRNA of its own. **(C)** ADAR1 converts Adenosine-to-Inosine (A-to-I), and then, inhibits circRNA biosynthesis by breaking RNA--RNA interactions that form during RNA base-pairing. **(D)** The presence of QKI binding sites in the intron of genes is able to trigger circRNA production. mRNA, messenger RNA; circRNA, circular RNA; pre-mRNA, precursor mRNA; ecircRNA, exonic circRNA; ciRNA, intronic circRNA; ElciRNA, exon--intron circRNA.](fncel-11-00354-g001){#F1}

*Cis*- and *Trans*- Regulators of circRNA Biogenesis
----------------------------------------------------

In addition to the splicing machinery, both *cis*-regulatory elements and *trans*-acting factors are needed to bring the two splice sites into close proximity to facilitate back-splicing ([@B43]; [@B50]). For example, reverse and complementary sequences resided in flanking introns of circulated exons are able to form RNA duplexes, which enhance the efficiency of back-splicing ([@B42]; [@B104]). RNA duplexes can form by repetitive sequences such as *Alu* elements ([@B49]; [@B44]), as well as from non-repetitive but complementary sequences ([@B104]). Longer complementary sequences in general have stronger RNA pairing strengths and enhanced circRNA biogenesis than shorter sequences; however, sequences as short as 30 nts also possess the ability to stimulate circRNA production ([@B55]). In addition, distinct ways of RNA pairing can lead to generation of different circRNAs. For example, repetitive sequences such as *Alu* elements can form different combinations of *Alu* pairs, which results in production of diverse circRNAs from a single gene -- a process known as alternative circularization ([@B44]) (**Figure [1A](#F1){ref-type="fig"}**). The types and expression levels of circRNAs are much higher in humans than in mice, and the increased circRNA complexity during species evolution is correlated with an increased number and RNA-pairing capability of those complementary sequences ([@B18]). Importantly, in addition to RNA base-pairing formed across flanking introns, RNA base-pairing can also form within an individual intron in linear RNA production ([@B40]; [@B104]). Therefore, there are competitions between non-canonical splicing and canonical splicing, based on choice of RNA base-pairing in flanking introns or within an individual intron ([@B44]; [@B31]).

*Trans*-acting factors such as RNA-binding proteins (RBPs) have been reported to be capable of regulating circRNA biogenesis ([@B7]; [@B15]; [@B20]). Three factors, muscleblind (MBL), Adenosine deaminae 1 acting on RNA (ADAR1) and quaking (QKI) have been shown so far to regulate circRNA production by different mechanisms ([@B3]; [@B42]; [@B15]). MBL is a conserved regulator of RNA splicing. The second exon of MBL can be circularized to produce a circular transcript (called circMbl) and circMbl and its flanking introns have abundant MBL binding sites ([@B3]). These sites are required for circMbl biogenesis and therefore, MBL protein can control the production of the circRNA of its own ([@B3]) (**Figure [1B](#F1){ref-type="fig"}**). ADAR1 expression is negatively correlated with production of certain circRNAs ([@B87]). ADAR1 converts Adenosine-to-Inosine (A-to-I), which predominantly occurs in double-stranded *Alu* repeats ([@B4]). Therefore, it is thought that ADAR1 inhibits circRNA biosynthesis by breaking the RNA stem of RNA-RNA interactions that form during RNA base-pairing ([@B42]) (**Figure [1C](#F1){ref-type="fig"}**). QKI regulates the production of many circRNAs and the presence of QKI binding sites in the intron of genes that are normally spliced in a linear fashion is sufficient to trigger circRNA production ([@B15]) (**Figure [1D](#F1){ref-type="fig"}**).

It was reported that circRNA production occurs post-transcriptionally, since a 3′ end processing signal is necessary for back-splicing and the 3′ polyadenylation is required for splicing of some introns ([@B55]). Nevertheless, other studies point out that circRNA biogenesis can occur both co-transcriptionally and post-transcriptionally, and the strength of base-pairing of complementary sequences in the flanking intronic repeats determines whether back-splicing occurs co- or post-transcriptionally ([@B98]; [@B3]; [@B50]). While back-splicing mediated by minimal intronic repeats \[\<40 nucleotides (nt)\] requires 3′ end processing and occur post-transcriptionally, long flanking repeats (∼400 nt) are able to produce circRNAs co-transcriptionally ([@B50]).

CircRNAs in CNS Development
===========================

Central nervous system development is a complex and orderly process that requires precise regulation of proliferation and differentiation of progenitor cells and is intricately controlled by gene networks ([@B27]; [@B94]). Expression of circRNAs during CNS development is tissue-specific and stage-associated ([@B93]; [@B19]; [@B92]). In addition, circRNAs were reported to be preferentially back-spliced from neural genes and were widely and dynamically expressed in the brain. Therefore, circRNAs might play important roles in various processes of CNS development ([@B93]; [@B102]; [@B33]; [@B25]).

CircRNAs in Progenitor Cell Proliferation and Neural Differentiation
--------------------------------------------------------------------

Proliferation and differentiation of neurons from stem cell precursors and progenitors are landmarks of neural development. NcRNAs such as miRNAs and lncRNAs have been shown to be important in these processes ([@B75]). Similarly, circRNAs have also become increasingly recognized to play crucial roles. During neural development, the expression pattern of neuronal circRNAs show conservation between mouse, pig, and human, and the highly expressed circRNAs is more conserved than average, indicating that these highly expressed circRNAs are potentially more important ([@B97]; [@B79]) than others. In cell culture models of neural differentiation, the expression of the majority of circRNAs was shown to be significantly up-regulated ([@B79]). The host genes of these upregulated circRNAs are known to play essential roles in neuronal activities such as dendritic mRNA transport and synaptic membrane exocytosis ([@B69]; [@B36]; [@B45]). In addition, during porcine brain development, different anatomic regions were found to have different circRNA expression levels, with the minimum amount in the brain stem and the highest amount in the cortex and cerebellum ([@B93]). Moreover, at different stages of neural differentiation, there are distinct levels and types of up-regulated circRNAs ([@B79]). Taken together, circRNA expression is spatio-temporally regulated during brain development, suggesting that they may play an essential role in the process of neural proliferation and differentiation ([@B79]; [@B17]).

How do circRNAs control progenitor cell proliferation and neural differentiation? The origin of circRNAs may reflect their functions to some extent, assuming circRNAs have similar biological function to their host genes ([@B79]; [@B93]). In a study investigating spatio-temporal expression patterns of circRNAs during porcine embryonic brain development, three host gene associated pathways, Wnt signaling, axon guidance and the TGFβ signaling pathway, were found to be overrepresented at a developmental stage corresponding to major neurogenesis ([@B93]). These over-represented signaling pathways play a major role in neural stem cell proliferation, migration and differentiation ([@B78]; [@B63]). How circRNAs impact these pathways remains to be an important question in understanding their contributions to neural proliferation and differentiation.

CircRNAs in Synaptogenesis
--------------------------

The expression change, localization and origin of circRNAs signify the importance of circRNAs in synaptogenesis to a large degree. During porcine and mouse brain maturation, the amount of circRNAs produced was found to be significantly increased, especially when synaptic connections and neural network forms ([@B93]; [@B102]). For example, in mice, the expression pattern of most circRNAs changes abruptly at postnatal day (P)10 when synaptogenesis begins ([@B102]). Moreover, circRNAs originated from synapse-related genes are consistently up-regulated during the establishment of mature neural networks ([@B102]). In addition, consistent with a fourfold increase of synaptic density in the human cortex compared to mice ([@B37]), higher levels of circRNAs were detected in human brains compared to mouse brains. Moreover, instead of being equally distributed in all neuronal compartments, circRNAs are highly enriched in synaptoneurosomes ([@B102]). Although both circRNAs and mRNAs can be detected in the cell body and dendrites, they are not co-localized. For example, circStau2a is mainly presented in synapses; however, the linear Stau2a mRNA transcripts primarily locate in the cytoplasm ([@B93]). Furthermore, neural circRNAs are disproportionally originated from host genes encoding proteins with synaptic functions. Genes related to synapse, synapse part, presynaptic active zone, presynaptic membrane and postsynaptic density can give rise to abundant circRNAs ([@B93]; [@B102]). For example, circHomer1_a, a circRNA originated from *Homer1* that encodes a key protein in postsynaptic density regulation ([@B68]), has the highest expression level during synaptic plasticity ([@B102]).

The function of circRNAs in mammalian brain remains elusive. Because of their primary localization to synapses, it has been hypothesized that circRNAs may function as topologically complex platforms which recruit ribonucleoprotein (RNP) granules and transport required RNAs and proteins ([@B79]) that are needed for synaptogenesis when synaptic connections forms ([@B102]). Moreover, due to their great stability and specificity, circRNAs might be used as synaptic tags to keep a molecular memory ([@B79]). Another possible function for circRNAs is to serve as miRNA sponges ([@B34]). Certain circRNAs have been shown to contain multiple binding sites for core regions of miRNAs ([@B34]; [@B110]). It is possible that circRNAs can serve as competitive inhibitors for miRNA activities by inhibiting binding of miRNAs to their target transcripts. Multiple studies have shown that miRNAs play an important role in synapse formation, stabilization and plasticity ([@B74]; [@B64]). Therefore, circRNAs may indirectly control synaptogenesis through regulating activities of synapse-related miRNAs and the expression of miRNA targeted mRNAs ([@B34]; [@B110]).

CircRNAs in CNS Diseases
========================

CircRNAs play essential role in various processes of CNS development and might impact the function of aging brain ([@B97]; [@B29]), Recently, circRNAs have been investigated in neurological diseases ([@B12]; [@B83]; [@B52]). In addition, circRNAs have shown great potential to serve as prognostic biomarkers of many diseases due to their stability, specificity, sensitivity, and conservation ([@B66]; [@B79]; [@B61]).

CircRNAs in the Pathogenesis of CNS Diseases
--------------------------------------------

Several circRNAs were shown to function as miRNA sponges that sequester miRNAs and affect their interaction with downstream mRNAs ([@B26]; [@B73]) and an abnormal circRNA-miRNA-mRNA system has been indicated in the pathogenesis of CNS diseases ([@B52]; [@B111]). For example, Alzheimer's disease (AD), a progressive neurodegenerative disorder, is caused by damage to synapses, neuronal cell bodies and axons due to the accumulation of pathological amyloid-β or hyper-phosphorylated Tau in the brain ([@B14]). miRNA-7 is abundant in the brain and can directly regulate the expression of AD-related genes such Ubiquitin protein ligase A, which mediates the clearance of amyloid peptides in AD ([@B108]). A circRNA, ciRS-7 (circRNA for miRNA-7), also termed as cerebellar degeneration-related protein 1 antisense RNA (Cdr1as), contains more than 70 selectively conserved anti-miRNA-7 sequences, thus acting as competing endogenous sponges to efficiently quench normal miRNA-7 activities ([@B34]). miRNA-7 and ciRS-7 were found to be co-expressed in cultured primary murine neurons and in mouse brain sections ([@B34]). In addition, expression of ciRS-7 is significantly reduced in hippocampus of AD patients ([@B59]), suggesting an abnormal miRNA-circRNA system may underline the disease mechanism of AD (**Figure [2](#F2){ref-type="fig"}**). Because of the importance of miRNA-7 in other diseases such as cancer and Parkinson's disease ([@B46]; [@B82]; [@B57]), it is possible that ciRS-7 may exert a regulatory role in brain cancer and other neurodegenerative diseases as well. Deleting the ciRS-7 locus in mice leads to dysfunctional synaptic transmission and abnormal neuropsychiatric-like behavior in mice ([@B73]). Other than miR-7, ciRS-7 also has a binding site to miR-671. Interestingly, the expression of miR-7 and miR-671 were both deregulated in all brain regions in ciRS-7 deficient mice; however, the direction of changes was opposite. It was thought that the binding site on ciRS-7 is completely complimentary to miR-671, and the interaction of these two molecules could lead to AGO mediated ciRS-7 slicing and miR-671 degradation. In contrast, the binding sites for miR-7 are partially complimentary which cannot trigger ciRS-7 cleavage, leading to stabilized miR-7. Therefore, it is possible that circRNAs can serve as a platform to store and transport certain miRNAs. Similarly, another circRNA generated from the gene *Sry*, has 16 putative binding sites to miR-138 and can attenuate activity of miR-138 in culture ([@B34]). Expression of miR-138 was increased in cell culture models of AD suggesting the role of circRNA Sry in the disease pathology ([@B95]).

![Possible role of ciRS-7 in AD. CiRS-7 contains more than 70 selectively conserved anti-miRNA-7 sequences, thus acting as competing endogenous sponges to efficiently quench normal miRNA-7 activities. However, the expression of ciRS-7 is significantly reduced in hippocampus of AD patients. The abnormal miRNA-circRNA system might result in the abnormal mRNA expression of the target genes of miRNA-7. Therefore, the abnormal circRNA-miRNA-mRNA system may underline the disease mechanism of AD. miRNA, microRNA; circRNA, circular RNA; ciRS-7, circRNA for miRNA-7; AD, Alzheimer's disease.](fncel-11-00354-g002){#F2}

Other functions of circRNA in the CNS may be indicated by their host genes. For example, expression and complexity of circRNAs peak at embryonic day (E)60 during porcine brain development when dramatic morphological changes occur in the cortex. The top three highly expressed circRNAs at E60 are circCSPP1, circHDAC2 and circRIMS2 ([@B93]). The host genes of these circRNAs are crucial for CNS development and synaptic formation ([@B2]). For instance, CSPP1 plays a part in the normal physiological functions of primary cilia and mutations in this gene lead to a developmental brain disorder called Joubert syndrome ([@B91]). HDAC2 is important for neuronal survival and forebrain-specific deletion of this gene can lead to excessive repetitive behaviors in mice ([@B62]). RIMS2 are involved in synaptic vesicles release and presynaptic plasticity and deletion of this gene can result in decreased activation of the presynaptic Ca^2+^-channel ([@B47]). CircRNAs might also play a role in nerve damage. Biosynthesis of circHomer1 may compete with synthesis of Homer1b/c mRNA ([@B102]). In an *in vitro* model inducing synaptic plasticity using primary hippocampal neurons, circHomer1a expression was remarkably increased, which could inhibit potential overexpression of Homer1b/c that is detrimental to synaptic plasticity ([@B102]). Down-regulation of Homer1b/c was also shown to improve neuronal survival in an *in vitro* traumatic nerve injury model ([@B24]). Therefore, circHomer1a may have great potential as a therapeutic target on repair and regeneration of injured nerves.

CircRNAs as Potential Biomarkers in CNS Disorders
-------------------------------------------------

Due to lack of 3′ termini, circRNAs are generally endowed with a strong resistance to exonuclease RNase R, thus being more stable than linear RNAs ([@B65]; [@B23]). The great stability and abundance of circRNAs make them as great candidates for molecular biomarkers in neurological diseases. Recently, several studies have reported the use of circRNAs as potential diagnostic biomarkers for atherosclerotic vascular disease, pre-diabetes and varieties of tumors including gastric cancer, hepatocellular carcinoma, lung cancer, colon carcinoma, laryngeal cancer and leukemia, et al ([@B77]; [@B99]; [@B109]). For example, circPVT1 could act as independent prognostic marker in gastric cancer ([@B8]). The expression of circPVT1 was up-regulated in gastric cancer tissues and it could promote cell proliferation through serving as a sponge for miR-125 family members ([@B8]). Also, similarly, circular RNA hsa_circ_0000190 was down-regulated in both human gastric cancer tissues and plasma samples and had higher sensitivity and specificity compared with traditional gastric cancer biomarkers, carcinoembryonic antigen (CEA) and CA19-9 ([@B11]). So far, multiple circRNAs have been explored as a biomarker for a variety of diseases especially in cancer ([@B67]).

Neural circRNAs show high conservation during evolution and are abundantly expressed in the brain ([@B93]). In Drosophila, circRNA expression increased substantially during CNS aging and could be regarded as a class of aging biomarkers ([@B97]). Accumulation of circRNAs in aging brains has also been described in mice ([@B29]) suggesting it could be a general theme for other species including humans. Therefore, although it has not been reported in CNS diseases, because circRNAs are stable, specific, conserved and sensitive, distinct circRNA profiles may be used to evaluate the physiologic and pathological circumstances in the brain ([@B65]; [@B79]; [@B85]). On the other hand, biopsies for neuronal tissues may be difficult to access. However, the pathological information of CNS tissues could be acquired through detecting the levels of certain components in the plasma and cerebrospinal fluid, etc. that are easily accessible ([@B60]). Therefore, detecting circRNAs from these sources can be possible and using circRNAs as biomarkers for neurological diseases should be further investigated.

Furthermore, in CNS diseases, the blood--brain barrier (BBB) can be compromised and small molecules including circRNAs and exosomes can be transported out of BBB ([@B28]). Exosomes are membranous small vesicles that can transfer circRNA, miRNA, mRNA and protein into extracellular fluid or cells ([@B13]). Recent studies revealed that, circRNAs contained in exosomes (exo-circRNAs) were about twice more than those in their producer cells ([@B53]). CircRNAs tend to be more accessible to exosomes than linear RNAs, and the ratio of exo-circRNAs to their linear transcripts in exosomes is about six times higher than that in their producer cells ([@B53]) (**Figure [3](#F3){ref-type="fig"}**). In addition, exo-circRNAs showed high stability, perhaps because of their protein partners and the protection of exosomes ([@B53]). Taking together, the specific circRNAs profiles carried in exosomes might serve as potential biomarkers in CNS disorders ([@B58]).

![CircRNAs as potential biomarkers in CNS disorders. Due to lack of 3′ termini, circRNAs are generally endowed with a strong resistance to exonuclease RNase R, thus being more stable than linear RNAs. Furthermore, in CNS diseases, the blood--brain barrier (BBB) can be compromised and small molecules including circRNAs and exosomes can be transported out of BBB. CircRNAs contained in exosomes (exo-circRNAs) were about twice more than those in their producer cells. CircRNAs tend to be more accessible to exosomes than linear RNAs, and the ratio of exo-circRNAs to their linear transcripts in exosomes is about six times higher than that in their producer cells. In addition, exo-circRNAs showed high stability, perhaps because of their protein partners and the protection of exosomes. Thus, the great stability and abundance of circRNAs make them as great candidates for molecular biomarkers in neurological diseases. mRNA, messenger RNA; circRNA, circular RNA; miRNA, microRNA; BBB, blood--brain barrier; exo-circRNAs, circRNAs contained in exosome.](fncel-11-00354-g003){#F3}

Future Exploration
==================

Despite of recent discoveries that significantly expanded our knowledge on circRNAs ([@B16]; [@B51]; [@B26]), there are still questions remain to be answered regarding circRNA biogenesis and their biological functions. These questions include: (i) how the spliceosome acts during the course of back-splicing reaction and the exact kinetics of back-splicing are currently not well known. (ii) In addition to acting as miRNA and RBP sponges, circRNAs could transport required RNAs and proteins and recruit ribonucleoproteins. However, we do not know enough details about the topological structure of circRNAs and how they interact with ribonucleoproteins and other RNAs. (iii) Neural circRNAs are abundant, conserved and spatio-temporally regulated. However, what controls the selectively high expression of certain neural circRNAs and the relative balance between the expression of circRNAs and their linear transcripts during CNS development is not known. (iv) In CNS development, how the highly expressed circRNAs act and how they are degraded are not clear. (v) Though miRNA sponge is the only known function for some circRNAs, other functions of most of circRNAs in the brain are not known. (vi) CircRNAs in certain tissues or in exosomes show high abundance and stability, but detection of their existence in exosomes can be costly. Thus, efficiency and convenient methods used for detecting circRNAs in exosomes are required for their widespread use as biomarkers. (vii) The repeatability, reliability and security of using circRNAs as biomarkers or therapeutic targets need to be further studied due to their complex roles in the body.
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